---
title: "NITO.US (NITO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NITO.US/news.md"
symbol: "NITO.US"
name: "NITO.US"
parent: "https://longbridge.com/en/quote/NITO.US.md"
datetime: "2026-05-20T13:51:44.714Z"
locales:
  - [en](https://longbridge.com/en/quote/NITO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NITO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NITO.US/news.md)
---

# NITO.US (NITO.US) — Related News

### [High Growth Tech Stocks to Watch in March 2026](https://longbridge.com/en/news/280962302.md)
*2026-03-30T05:53:36.000Z*
> As geopolitical tensions and fluctuating energy prices impact the STOXX Europe 600 Index, investors are focusing on high

### [](https://longbridge.com/en/news/276924751.md)
*2026-02-25T18:07:14.000Z*
> N2OFF shares are trading higher after the company announced a corporate rebranding to Nexentis Technologies and change i

### [U.S. stock market midday update: N2OFF drops over 10% with a surge in trading volume, market sentiment fluctuations attract attention](https://longbridge.com/en/news/276638340.md)
*2026-02-23T19:52:27.000Z*
> N2OFF fell 10.66%; Kediwa Agricultural Technology fell 0.11%, with a transaction volume of USD 146 million; Meisheng fel

### [US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%](https://longbridge.com/en/news/276635158.md)
*2026-02-23T19:00:21.000Z*
> Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and bi

### [N2OFF, Inc. Provides Early Warning Disclosure](https://longbridge.com/en/news/276374403.md)
*2026-02-19T20:20:20.000Z*
> N2OFF, Inc. has issued an early warning disclosure as required by National Instrument 62-103 due to a change in its owne

### [MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases | NITO Stock News](https://longbridge.com/en/news/275755579.md)
*2026-02-12T04:25:00.000Z*
> MitoCareX Bio, a subsidiary of N2OFF, Inc., reported successful in vitro results showing that its MITOLINE™-powered smal